Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment-Reference-Cited by-同舟云学术

Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment

Published:2018-02 Issue: Volume:20 Page:6-8
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Barone Stefania,Scannapieco Sara,Torti Carlo,Filippelli Enrica,Pisani Vincenzo,Granata Alfredo,Console Domenico,Demonte Giulio,Tallarico Tiziana,Polidoro Serena,Quattrone Aldo,Valentino Paola

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference11 articles.

1. Drug-induced liver injury;Abboud;Drug Saf.,2007

2. Opportunistic infections after alemtuzumab: new cases of norcardial infection and cytomegalovirus syndrome;Brownlee;Mult. Scler.,2017

3. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab;Clerico;Mult. Scler.,2017

4. Phase II study of alemtuzumab in chronic lymphoproliferative disorders;Ferrajoli;Cancer,2003

5. Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis;Hartung;Mult. Scler.,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus and Other Herpesviruses;Infectious Complications in Biologic and Targeted Therapies;2022

2. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review;CNS Drugs;2021-07-28

3. Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies;Expert Opinion on Drug Safety;2021-07-26

4. The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement;Multiple Sclerosis Journal;2020-09-17

5. The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis;Cells;2020-06-03